These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1975344)

  • 1. What is known about the prevention of congenital toxoplasmosis?
    Jeannel D; Costagliola D; Niel G; Hubert B; Danis M
    Lancet; 1990 Aug; 336(8711):359-61. PubMed ID: 1975344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital toxoplasmosis and prenatal care state programs.
    Avelino MM; Amaral WN; Rodrigues IM; Rassi AR; Gomes MB; Costa TL; Castro AM
    BMC Infect Dis; 2014 Jan; 14():33. PubMed ID: 24438336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a preventive program for congenital toxoplasmosis.
    Ghidini A; Sirtori M; Spelta A; Vergani P
    J Reprod Med; 1991 Apr; 36(4):270-3. PubMed ID: 2072359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of congenital toxoplasmosis].
    Russo M; Galanti B
    Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women].
    Garin JP; Pellerat J; Maillard ; Woehrle R; Hezez
    Presse Med (1893); 1968 Dec; 76(48):2266. PubMed ID: 5720932
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of Toxoplasma gondii infection during pregnancy.
    Montoya JG; Remington JS
    Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and treatment of materno-fetal toxoplasmosis].
    Fortier B; Ajana F; Pinto de Sousa MI; Aissi E; Camus D
    Presse Med; 1991 Sep; 20(29):1374-83. PubMed ID: 1835012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fetomaternal therapeutic follow-up of spiramycin during pregnancy].
    Forestier F; Daffos F; Rainaut M; Desnottes JF; Gaschard JC
    Arch Fr Pediatr; 1987; 44(7):539-44. PubMed ID: 3426376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital toxoplasmosis: prevention, screening and treatment.
    Holliman RE
    J Hosp Infect; 1995 Jun; 30 Suppl():179-90. PubMed ID: 7560949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of congenital toxoplasmosis.
    Petersen E
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):285-93. PubMed ID: 17402843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of antenatal spiramycin treatment on the frequency of retinochoroiditis due to congenital toxoplasmosis in a Colombian cohort].
    Zuluaga LM; Hernández JC; Castaño CF; Donado JH
    Biomedica; 2017 Apr; 37(0):86-91. PubMed ID: 28527270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital toxoplasmosis: efficacy of maternal treatment with spiramycin alone.
    Vergani P; Ghidini A; Ceruti P; Strobelt N; Spelta A; Zapparoli B; Rescaldani R
    Am J Reprod Immunol; 1998 May; 39(5):335-40. PubMed ID: 9602252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of spiramycin in prevention of fetal toxoplasmosis.
    Avci ME; Arslan F; Çiftçi Ş; Ekiz A; Tüten A; Yildirim G; Madazli R
    J Matern Fetal Neonatal Med; 2016; 29(13):2073-6. PubMed ID: 26365472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Options for the pharmacotherapy of toxoplasmosis during pregnancy.
    Peyron F; Wallon M
    Expert Opin Pharmacother; 2001 Aug; 2(8):1269-74. PubMed ID: 11584994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programs for control of congenital toxoplasmosis.
    Lopes-Mori FM; Mitsuka-Breganó R; Capobiango JD; Inoue IT; Reiche EM; Morimoto HK; Casella AM; Bittencourt LH; Freire RL; Navarro IT
    Rev Assoc Med Bras (1992); 2011; 57(5):594-9. PubMed ID: 22012297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital toxoplasmosis: prevention or palliation?
    Frenkel JK
    Am J Obstet Gynecol; 1981 Oct; 141(4):359-61. PubMed ID: 7282820
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital toxoplasmosis.
    Olliaro P
    Clin Evid; 2002 Jun; (7):623-6. PubMed ID: 12230689
    [No Abstract]   [Full Text] [Related]  

  • 20. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy.
    Wallon M; Liou C; Garner P; Peyron F
    BMJ; 1999 Jun; 318(7197):1511-4. PubMed ID: 10356003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.